Overview
Investment Type
Venture Capital
Mentions in press and media 13
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 2, 2012 | Former head of Sanofi vaccines division becomes infectious disease biotech CEO | Last year, it was granted a five-year research grant valued up to $196 million by the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services, to fund the development of seasonal and ... |
| Jan 25, 2012 | Mevion Medical Systems Closes $45M Funding | Mevion Medical Systems, Inc. (formerly known as Still River Systems, Inc.) a Littleton, MA-based radiation therapy company dedicated to advancing the treatment of cancer, has closed a $45m funding. Backers include ProQuest Investments and e... |
| Dec 11, 2009 | Indiana’s Dormir acquires 15 sleep-therapy centers in Western U.S. | Miller told the Indianapolis Business Journal in July that Dormir would look to acquire competitors that had been financially weakened due a change in Medicare rules that decreased reimbursement for medical equipment and non-hospital-affili... |
| Jul 28, 2009 | Dormir completes $12 million Series A round for sleep-center expansion | Sleep centers are moving from “mom and pop shops” to more consolidated and professional services — due in part to new licensing regulations, said Juan Enriquez, a managing director at Excel. “The thing we’re finding out about sleep disorder... |
| Jun 5, 2009 | Innovation rules the week at MedCity News — Weekend Rounds, June 5, 2009 | Then Dormir, the Indiana parent company that oversees firms that build sleep centers and provide respiratory care services, raised $8 million to grow both businesses. CHL Medical Partners and Noro-Moseley Partners led the round. Dormir Chi... |
| Jun 1, 2009 | Dormir raises $8 million to grow MD Sleep, CardioSom | Promoted Clinical Care Capacity Planning Learn how to manage clinical care capacity more efficiently during uncertain times. SAP Promoted Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis has undermin... |
| Jun 5, 2007 | Antibiotic maker BioRelix gets $26M | BioRelix, a New Haven, Conn., developer of new antibiotics, raised $25.75 million in a first funding round, VentureWire reports (subscription required). The round included New Leaf Venture Partners, Aisling Capital, CHL Medical Partners, No... |
| Innovation rules the week at MedCity News — Weekend Rounds, June 5, 2009 | CLEVELAND, Ohio — Innovation in medical devices. Innovation in vaccines. Even innovation in regulating drug development — MedCity News saw it all last week. The week started with the appointment of a new chairman for the National Venture... | |
| Dormir completes $12 million Series A round for sleep-center expansion | CARMEL, Indiana — New health investor Excel Venture Management has added $4 million to complete a $12 million Series A round for Dormir, the sleep-therapy services and equipment provider, the companies announced Wednesday. Dormir had by lat... |
Show more
Reviews 0
FAQ about CHL Medical Partners
What has the press written about CHL Medical Partners?
Parsers VC has collected 13 articles mentioning CHL Medical Partners, among them “Former head of Sanofi vaccines division becomes infectious disease biotech CEO” (Apr 2, 2012) and “Mevion Medical Systems Closes $45M Funding” (Jan 25, 2012).
Is CHL Medical Partners still active?
CHL Medical Partners is probably closed: its latest activity on Parsers VC dates from Jun 26, 2013.